Current Issue
Glaucoma News Briefs
- FDA Approves Hydrus MIGS Device
- FDA Clears IOP Measuring Device
- Santen Begins Phase 3 Trials for Glaucoma Agonist
- Nidek Launches New Type of Gonioscope
- Contact Lens Changes Color As It Releases Drugs
- iStent Effective in Severe Glaucoma
- Metrovision Launches Perimeter in US Market
- Oculus Introduces Smartfield Perimeter
- Bariatric Surgery Can Lower IOP
- Xelpros Approved as BAK-Free Latanoprost
- European Regulators Accept Rhopressa Application
- Optometrists’ Adherence to AAO Glaucoma Guidelines
- Immune Cells May Play Role in Glaucoma Vision Loss
- MIGS Drives Growth in Glaucoma Device Market
- Aflibercept Reduces IOP in Neovascular Glaucoma Study
- Topcon Gets Clearance for Laser Software
Featured Articles in the Current Issue
-
Optical Coherence Tomography Angiography for Glaucoma Diagnosis and Follow-Up
Essential to practice or still a research tool?
-
Four Reasons to Consider Electrophysiologic Testing
In conjunction with clinical exams, this test can provide insights that better direct glaucoma treatment.
-
Glaucoma Screening in 2018
The when, why, how, and who of screening for glaucoma.
-
Choosing a Winner for You and Your Surgical Patient
Considerations for learning and incorporating MIGS.
Departments and Columns
-
From the Editor: Today’s MIGS Landscape
The FDA and industry collaborate to ensure safety.
-
-
Glaucoma Myth Busters: Myths About Endoscopic Cyclophotocoagulation
A MIGS procedure with an excellent safety profile.
-
Patients Are Asking: What Should My Eye Pressure Be?
The answer is not as simple as you might think.
-
Product Spotlight: Microstent Uses Three-Prong Approach to Lower IOP
The rigorously studied device has impressive efficacy and safety records.